Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredients:




Dosage Form:

New Zealand Sponsor:
Manufacturer:

Plasma-Lyte 148, pH 7.4
Magnesium chloride hexahydrate 0.3g/L
Potassium chloride 0.37g/L
Sodium acetate trihydrate 3.68g/L
Sodium chloride 5.26g/L
Sodium gluconate 5.02g/L
Solution for infusion
Baxter Healthcare Limited
Baxter Healthcare Pty Limited, Sydney, Australia

Product:
Active Ingredients:

Dosage Form:

New Zealand Sponsor:
Manufacturer:

Potassium 40mmol and 0.9% Sodium Chloride
Potassium chloride 29.8g/L
Sodium chloride 9g/L
Solution for infusion
Baxter Healthcare Limited
Baxter Healthcare Pty Limited, Sydney, Australia

Product:

Active Ingredients:



Dosage Form:

New Zealand Sponsor:
Manufacturer:

Potassium Chloride 20mmol in 4% Glucose
and 0.18% Sodium Chloride

Glucose 40g/L
Potassium chloride 1.5g/L
Sodium chloride 1.8g/L
Solution for infusion
Baxter Healthcare Limited
Baxter Healthcare Pty Limited, Sydney, Australia

Product:

Active Ingredients:



Dosage Form:

New Zealand Sponsor:
Manufacturer:

Potassium Chloride 30mmol in 4% Glucose
and 0.18% Sodium Chloride (Baxter)
Glucose 40g/L
Potassium chloride 2.24g/L
Sodium chloride 1.8g/L

Solution for infusion
Baxter Healthcare Limited
Baxter Healthcare Pty Limited, Sydney, Australia

Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Tygacil
Tigecycline 50mg
Powder for infusion
Pfizer New Zealand Limited
Patheon Italia SpA, Milan, Italy
Wyeth Lederle SrL, Catania, Italy

Dated this 17th day of February 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).